Annotated Medicine and Device Lists
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 1.1.1. Inhalational medicines | No observations |
| Brazil (incomplete list) | A.1.1. Agentes de inalação e oxigênio |
Others observations: Uso hospitalar, compreendendo emprego de medicamentos em pacientes internados ou em pacientes de ambulatório que necessitam de atendimento especializado ou ainda quando a administração implique risco à saúde. |
| Bolivia | LINAME 2011 - 2013 | No observations |
| Peru | 1.1 General Anesthetics and Oxygen | No observations |
| Chile | Essential and Prioritized Medications | No observations |
| Colombia | 11.3 Others | No observations |
| Training CSamouge 2022 | 1.1.1 Inhalational medicines | No observations |
| Training CSamouge 2022 | 1.4 Medical gases |
Others observations: For use in the management of hypoxaemia. No more than 30% oxygen should be used to initiate resuscitation of neonates less than or equal to 32 weeks of gestation. |
| WHO Model List of Essential Medicines (2021) | 1.4 Medical gases |
Others observations: For use in the management of hypoxaemia. No more than 30% oxygen should be used to initiate resuscitation of neonates less than or equal to 32 weeks of gestation. |